These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21327890)

  • 1. Future perspectives on neuroendocrine tumors.
    Castellano D; Salazar R; Raymond E
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():35-40. PubMed ID: 21327890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.
    Turaga KK; Kvols LK
    CA Cancer J Clin; 2011; 61(2):113-32. PubMed ID: 21388967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin and somatostatin receptors: from basic concepts to clinical applications.
    De Martino MC; Hofland LJ; Lamberts SW
    Prog Brain Res; 2010; 182():255-80. PubMed ID: 20541669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current knowledge on diagnosis and staging of neuroendocrine tumors.
    Oberg K; Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.
    Srirajaskanthan R; Toumpanakis C; Meyer T; Caplin ME
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1143-54. PubMed ID: 19298583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
    Goldin SB; Aston J; Wahi MM
    Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the systemic treatment of pancreatic neuroendocrine tumors.
    Yalcin S
    Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors.
    Ploeckinger U; Kloeppel G; Wiedenmann B; Lohmann R;
    Neuroendocrinology; 2009; 90(4):349-63. PubMed ID: 19776553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
    Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
    Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
    Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
    Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
    Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.